CIK 0001681087
- Non-accelerated filer
- Smaller reporting company
Tectonic Therapeutic, Inc.
Sign in to watch- Ticker
- TECX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- Operating
- EIN
- 810710585
- Phone
- +1 339-666-3320
- Business address
- 490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
- Former names
- AvroBio, Inc., AVROBIO, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,920
- in 2 filings, $14K under 10b5-1 plans
Net −$13,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-02 | Ridha Essra Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2022-02-02 | Avruch Steven Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +105,000 | 105,000 | ||
| 2022-02-02 | Avruch Steven Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2022-02-02 | Ostrowski Erik Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +170,000 | 170,000 | ||
| 2022-02-02 | Ostrowski Erik Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +145,000 | 145,000 | ||
| 2021-11-01 | Ridha Essra Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2021-07-07 | Vickers Philip J. Director | Purchase | +4,800 | $8.35 | $40K | 4,800 |
| 2021-06-10 | Petersen Deanna M Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2021-06-10 | Mason Christopher Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2021-06-10 | Ostrowski Erik Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2021-06-10 | MACKAY GEOFFREY President & CEO | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2021-06-10 | Escolar Diana Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2021-06-10 | Avruch Steven Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2021-06-10 | Vickers Philip J. Director | Grant or award · Stock Option (Right to Buy) | +17,438 | 17,438 | ||
| 2021-06-10 | Farfel Gail M Director | Grant or award · Stock Option (Right to Buy) | +17,438 | 17,438 | ||
| 2021-06-10 | CLARK IAN T Director | Grant or award · Stock Option (Right to Buy) | +17,438 | 17,438 | ||
| 2021-06-10 | Jenkins Annalisa Director | Grant or award · Stock Option (Right to Buy) | +17,438 | 17,438 | ||
| 2021-06-10 | PAIGE CHRISTOPHER Director | Grant or award · Stock Option (Right to Buy) | +17,438 | 17,438 | ||
| 2021-06-10 | Booth Bruce Director | Grant or award · Stock Option (Right to Buy) | +17,438 | 17,438 | ||
| 2021-06-10 | Donenberg Phillip B. Director | Grant or award · Stock Option (Right to Buy) | +17,438 | 17,438 |
Page 12 of 17 · 322 trades